KBI Biopharma
North America, North Carolina, United States, Durham
Description
KBI Biopharma, Inc. (KBI) is a leading development and contract manufacturing organization serving the biopharmaceutical industry. We help
Investor Profile
KBI Biopharma has backed more than 5 startups, with 0 new investments in the last 12 months alone. The firm has led 3 rounds, about 60% of its total and boasts 3 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series D, Series A, Seed rounds (top funding stages).
- Majority of deals are located in United States, Ireland.
- Strong thematic focus on Biotechnology, Life Science, Artificial Intelligence (AI).
Stage Focus
- Series D (40%)
- Series A (40%)
- Seed (20%)
Country Focus
- United States (80%)
- Ireland (20%)
'/%3e%3cpath d='M200 752.362h200v300H200z' style='fill:%23fff;fill-opacity:1;stroke:none' transform='translate(0 -752.362)'/%3e%3cpath d='M400 752.362h200v300H400z' style='fill:%23ff883e;fill-opacity:1;stroke:none' transform='translate(0 -752.362)'/%3e%3c/svg%3e)
Industry Focus
- Biotechnology
- Life Science
- Artificial Intelligence (Ai)
- Biopharma
- Therapeutics
- Medical
- Health Care
- Health Diagnostics
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
